Analyst Ed Arce from H.C. Wainwright maintained a Buy rating on Akero Therapeutics (AKRO – Research Report ... that highlight the promising potential of Akero Therapeutics’ lead product candidate, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback